Citi on Alnylam Pharmaceuticals (ALNY): 'Opening 90-day Catalyst Watch for Onpattro APOLLO-B data announcement'
Tweet Send to a Friend
Citi analyst David Lebowitz reiterated a Buy rating and $211.00 price target on Alnylam Pharmaceuticals (NASDAQ: ALNY)Opens 90-Day Upside Catalyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
